EN
HI
Bacil Pharma Share price
BACPHAR
00.0
0 (0.00%)Last updated on 8 Sep, 2025 | 09:17 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
0.00
52 Week High
0.00
The current prices are delayed, login to your account for live prices
LoginBacil Pharma Chart
Bacil Pharma Share Key Metrics
Volume
0.00
Market Cap
20.65 CR
LTQ@LTP
0@0
ATP
0
Var Margin
100 %
Circuit Range
33.31-35.06
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
1
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
Bacil Pharma News
Bacil Pharma reports standalone net loss of Rs 0.08 crore in the September 2021 quarter
Nov 13 2021 15:15:35
Read More
About Bacil Pharma
NSE : 0
BSE : 524516
ISIN : INE711D01018
Bacil Pharma Management
| Name | Position |
|---|---|
| Mr. Shirish Shetty | Ind. Non-Executive Director |
| Mr. Lalit Jain | Ind. Non-Executive Director |
Bacil Pharma Similar Stocks
Gujarat Terce Laboratories Ltd.
41.50
1.64 (4.11%)
Vilin Bio Med Ltd.
0.00
0.00 (0.00%)
Transgene Biotek Ltd.
4.14
0.13 (3.24%)
Gujarat Inject (Kerala) Ltd.
20.11
-0.84 (4.01%)
Omkar Pharmachem Ltd.
25.56
0.00 (0.00%)
Ishita Drugs & Industries Ltd.
83.22
10.22 (14.00%)
Emmessar Biotech & Nutrition Ltd.
27.54
0.88 (3.30%)
Saroja Pharma Industries India Ltd.
0.00
0.00 (0.00%)
Beryl Drugs Ltd.
23.43
-1.02 (4.17%)
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 0.00 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 33.3 & 3.65 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 20.65 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 0.00 & 0.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.